Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
Genedrive plugging the event directly on Twitter today...
https://twitter.com/genedriveplc/status/1366311121133658117?s=19
@seamus12
It's all here on the website
https://www.amigoplc.com/investors/investor-faqs
Expected timetable in section "What is the timeframe for implementing this?"
The results of the PALOH (Pharmacogenetics to Avoid Loss Of Hearing) study trial, which took place last year using the Genedrive AIHL system, are being discussed by the principle investigator via Zoom on March 8th.
Hopefully the study trial results will give our system the endorsement needed to kick start sales on it's launch with our sales partner, Inspiration Healthcare, in June.
Another worthy and hopefully profitable string to our bow!
https://twitter.com/PALOH_Study/status/1362917055167660034?s=09
https://twitter.com/RebekahBrown92/status/1362769321206890496?s=09
@ Arthur
Section 8 Subsection B2 of the Notification
It's like Deja vu all over again..... :S
Badmashy wrote:
"What if thats why NDA is in place to not disclose details of agreement, so SP do not go Sky high and they can buy us cheaper."
It doesn't matter what NDAs are in play, you can't hide your accounts, even on AIM!
The NDA will only cover their commercial arrangement, not the actual monetary value on the company accounts.
ST
"The general consensus seems to be 200p by next week."
I never say never but that's a ramp even Evel Knievel would be proud of! Lol
(Google it kids.. )
I think this young company is starting to mature nicely.
Keeping a close eye on it, but so far it seems a good potential longer term investment which will hopefully produce a juicy dividend as well as capital growth in the future.
Rumours do Bouncyman
But I agree, at the moment there doesn't seem to be any real substance to drive this action but I'm watching with interest...
Mmmmm..my spidy senses are tingling here & tells me this aint quite right....
Lots of repetitive rampy posts today and at the weekend with no 'real' news forthcoming, all very Pumpty Dumpty...
Hope I'm wrong..
Sorry, should read 'LON:EHP' not 'LON:EHL', doh!
Looks like you've dug up a old article there.
Epistem Holdings LON:EHL was reborn as Genedrive LON:GDR back in 2016 I believe..
He may not be able to buy shares at this point because we are waiting for applied approvals, potential contractual awards and are launching two new products. Basically, any RNS on the above could shift the share price.
I can see it now on this board, screams of 'insider dealing' if he bought 200k of shares today and news came tomorrow or early next week. Even if no news were forthcoming and he bought a large amount, he could be accused of pumping his own share price because others may buy on the back of it.
Maybe after any news he could buy, then he couldn't possibly have any accusations levelled at him.
The idea of future bonuses/incentives as partially shares linked then maybe that could work.
Just my two penn'orth
GDR are not selling the AIHL Genedrive kit directly themselves.
They are partnered with Inspiration Healthcare who are specialists in supplying/distributing paediatric and neo-natal care products (amongst other things).
https://www.inspiration-healthcare.com/
They are a well run company who have had a bumper sales year in 2020.
So hopefully there should be many sales as long as GDR get the kit to production :)
"GDR raised money at 80p and anyone from there could have sold at £1.50. Sounds good. "
It does sound good doesn't it? Unfortunately however it was not a true picture. You make it sound as if the placement shares were easily obtainable, but in truth the share price was a lot higher than the placement price at the time and what portion of the placement shares that were made available to PI's was heavily over subscribed. Indeed, some applicants not receiving any.
Interesting DIVOC top man magazine interview article via a tweet.
https://health.economictimes.indiatimes.com/amp/news/diagnostics/auto-validation-of-diagnosis-and-touchless-inventory-are-promising-trends-that-can-deliver-high-standards-dr-kanav-kahol-ceo-divoc-labs/80051488?__twitter_impression=true
Mentions GDR Covid test, using an FDA approved POC solution and the future of DIVOC and its funding.
Hopefully the market we will stun,
When GDR is top in twenty-twenty one,
With POC and bead,
We are sure to succeed.
When others are spent and done.
Meanwhile if you write while awaiting news,
Be aware personal abuse can cause more than the blues,
So please be nice during our debate,
And remember - good things come to those who wait.....
...hopefully!
I like the idea... Genedrive, the Amazon of diagnostics (one day maybe!)
Sorry, I'll get my coat...
I don't want see any of BOD voted out at this time, but I would appreciate some 'real' transparency and updates as to our current trials, sales positions, potential partnerships/collaborations and overall outlook - and not just with our Covid products.
I understand there may have been extenuating circumstances and genuine commercial reasons for the path they've tred but we should not have been kept so in the dark. Throwing in comments about being 'very close' etc. and then not following it up is incredibly frustrating and that's when rumours and speculation starts which can spook the SP.
Sometimes just a little bit of 'fluff' can go a long way...
BTW - According to the AGM RNS, the AGM Q&A should be posted on their website afterwards - could make interesting reading.
@ LTH re 'target markets' from the CEO's own review Nov 2020 annual report
"We have focused only in specific target markets and obtained South African approval in September 2020 which was a clear validation of the product."
I hope you're right with your predictions tho' LTH - that single deep splodge of red on my portfolio is rather spoiling it's look...
I fully understand what I've 'dabbled' in LTH and many of my other 'dabblings' have done very well thank you.
However we have authorisations (CE/South Africa) and we have manufactured product stock (beads), but for no stated valid reason has there been any sales of said stock to said markets.
The 'that's not our target market' is pants ! Why get qualifications and authorisations in market you do not intend selling in to?